TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
ADPT

Adaptive Biotechnologies Corp

Healthcare · Diagnostics & Research

29.60$ +6.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADPT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – -172.9% – – – – –
– +3.5% +29.8% +8.7% +147.7% +34.2% -21.0% -13.4% -7.4%
– +59.1% +17.7% +88.7% +74.7% +28.3% +13.4% -14.8% -4.0%
– +29.5% +13.9% +120.0% +73.9% +30.7% – – –
– – – -116.0% – – – – –
– +152.1% +77.3% +67.9% +228.4% -73.5% -34.6% -65.7% -19.2%
– -98.0% -65,548.0% -75.7% – -98.4% +4,362.9% -40.0% -51.2%
– – – – – – – – –
– -97.5% +25,523.4% -9.6% -90.9% -70.5% – – –
– – – – – – – – –
– -97.5% +25,534.3% -8.2% -90.8% +387.2% -98.3% -89.3% +12,515.4%
– -158.7% – -38.4% -41.8% -413.7% – – –
– – – -186.8% – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?